Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence.
Debdulal ChakrabortySoumen MondalSubhendu BoralArnab DasTushar Kanti SinhaSaptorshi MajumdarRanabir BhattacharyaRitobroto MaitraPublished in: Clinical ophthalmology (Auckland, N.Z.) (2023)
Intravitreal injection of IRM and BRM show similar efficacy and safety in Indian eyes with nAMD.